Summary
The diagnostic procedure for gastric cancer involves the identification and treatment of cancerous cells in the stomach. This procedure is crucial for diagnosing stomach cancer.
Key procedures in the diagnostic process for gastric cancer include endoscopic procedures, biopsies, tissue tests, laboratory tests, in-vitro diagnostic tests, imaging tests, molecular diagnostics, multiplexing molecular diagnostics, immunoassays, and others. The endoscopic procedure involves the examination of internal organs, such as the gastrointestinal tract, by inserting a long, thin tube directly into the body. This endoscopy procedure is utilized in gastric cancer diagnosis, addressing both symptomatic and asymptomatic cases, and encompasses instruments, reagents and consumables, and services. Various body fluids, including blood, urine, saliva, stomach juice, and tissue, are required for the procedure. These fluids aid in the detection and treatment of both early and advanced gastric cancer.
The gastric cancer diagnostic procedure market research report is one of a series of new reports from The Business Research Company that provides gastric cancer diagnostic procedure market statistics, including the gastric cancer diagnostic procedure industry's global market size, regional shares, competitors with a gastric cancer diagnostic procedure market share, detailed gastric cancer diagnostic procedure market segments, market trends, and opportunities, and any further data you may need to thrive in the gastric cancer diagnostic procedure industry. This gastric cancer diagnostic procedure market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The gastric cancer diagnostic procedure market size has grown strongly in recent years. It will grow from $1.32 billion in 2023 to $1.43 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth witnessed in the historical period can be ascribed to advancements in biopsy techniques, augmented research funding, the evolution of biomarker discovery, enhanced pathological analysis, and changes in screening guidelines.
The gastric cancer diagnostic procedure market size is expected to see strong growth in the next few years. It will grow to $1.88 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The anticipated growth in the forecast period can be attributed to an increase in point-of-care testing, the introduction of novel biomarkers, a shift towards personalized medicine, the adoption of next-generation sequencing, and enhanced endoscopic imaging modalities. Major trends expected in the forecast period include the integration of nanotechnology, the adoption of big data analytics, the application of microbiota analysis, increased patient-centric approaches, and the role of telehealth in diagnostics.
The increasing prevalence of gastrointestinal diseases is a driving force behind the anticipated growth in the gastric cancer diagnostic procedure market. Gastrointestinal disorders encompass a range of illnesses affecting various sections of the digestive system and supporting organs, including the liver and pancreas. The gastric cancer diagnostic procedure is essential for addressing stomach cancer through methods such as endoscopy and biopsy. Therefore, the expanding incidence of gastrointestinal diseases is contributing to the market's growth. For instance, a study conducted by GI Associates & Endoscopy Center, a US-based medical facility specializing in gastroenterology services, involved 73,076 people from 33 nations, revealing that 40% of the subjects suffered from a functional gastrointestinal illness in August 2022. Hence, the increasing prevalence of gastrointestinal diseases is a significant factor propelling the growth of the gastric cancer diagnostic procedure market.
The rising prevalence of smoking is expected to drive the growth of the gastric cancer diagnostic procedure market in the future. Smoking involves the inhalation and exhalation of smoke produced by burning tobacco or other substances. Gastric cancer diagnostic procedures play a crucial role for individuals with a history of smoking or those at risk of smoking-related cancers by enabling early detection, identifying precancerous lesions, developing personalized treatment plans, facilitating communication and coordination, and providing a comprehensive assessment of the gastric mucosa and surrounding tissues. According to a report by The World Health Organization, a Switzerland-based intergovernmental organization, in July 2023, more than 8 million people are killed by tobacco each year, including 1.3 million non-smokers who inhale second-hand smoke. Therefore, the rising prevalence of smoking is a key driver of the growth of the gastric cancer diagnostic procedure market.
Technological advancements represent a prominent trend gaining momentum in the gastric cancer diagnostic market. Leading companies in the gastric cancer diagnostic market are actively incorporating new technologies to maintain their competitive positions. For example, in June 2022, Ibex Medical Analytics, an Israel-based provider of AI-powered diagnostics for health organizations, introduced Galen Gastric, the world's first AI-powered solution designed for gastric cancer detection. Galen Gastric serves as an integrated diagnostic tool assisting pathologists in identifying stomach cancer, H. pylori, and other critical clinical findings, contributing to faster turnaround times and improved diagnostic workflows.
Prominent companies in the gastric cancer diagnostic procedure market are strategically focusing on innovative products such as tissue staining platforms to drive revenue growth. The tissue staining platform aims to deliver rapid and precise test results, enabling medical professionals to make timely decisions regarding patient care. In June 2022, F. Hoffmann-La Roche AG, a Switzerland-based healthcare company, introduced the benchmark ultra plus system. This system, building on the proven technology of the benchmark ultra system, provides a fully automated workflow for immunohistochemistry (IHC) and in-situ hybridization (ISH) slide staining. It enhances the laboratory experience with features such as a retractable work surface, improved sliding drawers, indicator lights, and remote monitoring via a connected device, addressing user feedback. The system emphasizes efficient workflow, testing efficiency, and eco-friendly attributes.
In April 2021, Amgen, a US-based biopharmaceutical company, completed the acquisition of Five Prime Therapeutics for $1.9 billion. This strategic move enables Amgen to introduce innovative, best-in-class diagnostic products to the market, contributing to the growth of the company's presence in gastric cancer diagnostics and supporting its international expansion strategy. Five Prime Therapeutics, a US-based clinical-stage biotechnology company, specializes in providing gastric cancer diagnostic services.
Major companies operating in the gastric cancer diagnostic procedure market report are Pfizer Inc., Johnson & Johnson Co, F. Hoffmann La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories Inc., Sanofi SA, Eli Lilly and Company, Otsuka Pharmaceutical Co Ltd., AdventHealth, Atrium Health, Astellas Pharma Inc., Bausch Health Companies Inc., Agilent Technologies Inc., Ipsen Pharma, Hartford HealthCare, Myriad Genetics Inc., Myriad Genetics Inc., NovoCure Limited, Foundation Medicine Inc., Biocept Inc.
North America was the largest region in the gastric cancer diagnostics procedure market in 2023. The regions covered in the gastric cancer diagnostic procedure market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the gastric cancer diagnostic procedure market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The gastric cancer diagnostics procedure market includes revenues earned by entities that provide diagnostic procedures such as surgery, chemotherapy, and radiation therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
ページTOPに戻る
Table of Contents
1. Executive Summary
2. Gastric Cancer Diagnostic Procedure Market Characteristics
3. Gastric Cancer Diagnostic Procedure Market Trends And Strategies
4. Gastric Cancer Diagnostic Procedure Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Gastric Cancer Diagnostic Procedure Market Size and Growth
5.1. Global Gastric Cancer Diagnostic Procedure Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Gastric Cancer Diagnostic Procedure Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Gastric Cancer Diagnostic Procedure Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Gastric Cancer Diagnostic Procedure Market Segmentation
6.1. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Endoscopic Procedure
Biopsy
Tissue tests
Lab tests
In-vitro Diagnostic Tests
Imaging Tests
Molecular Diagnostics
Multiplexing Molecular Diagnostics
Immunoassays
Other Procedure Types
6.2. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Symptom Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Symptomatic
Asymptomatic
6.3. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Instruments
Reagents and Consumables
Services
6.4. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Body Fluid Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Blood
Urine
Saliva
Stomach Juice
Tissue
Other Body Fluid
6.5. Global Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Early Gastric Cancer
Advanced Gastric Cancer
7. Gastric Cancer Diagnostic Procedure Market Regional And Country Analysis
7.1. Global Gastric Cancer Diagnostic Procedure Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Gastric Cancer Diagnostic Procedure Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Gastric Cancer Diagnostic Procedure Market
8.1. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Gastric Cancer Diagnostic Procedure Market
9.1. China Gastric Cancer Diagnostic Procedure Market Overview
9.2. China Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Gastric Cancer Diagnostic Procedure Market
10.1. India Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Gastric Cancer Diagnostic Procedure Market
11.1. Japan Gastric Cancer Diagnostic Procedure Market Overview
11.2. Japan Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Gastric Cancer Diagnostic Procedure Market
12.1. Australia Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Gastric Cancer Diagnostic Procedure Market
13.1. Indonesia Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Gastric Cancer Diagnostic Procedure Market
14.1. South Korea Gastric Cancer Diagnostic Procedure Market Overview
14.2. South Korea Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Gastric Cancer Diagnostic Procedure Market
15.1. Western Europe Gastric Cancer Diagnostic Procedure Market Overview
15.2. Western Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Gastric Cancer Diagnostic Procedure Market
16.1. UK Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Gastric Cancer Diagnostic Procedure Market
17.1. Germany Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Gastric Cancer Diagnostic Procedure Market
18.1. France Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Gastric Cancer Diagnostic Procedure Market
19.1. Italy Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Gastric Cancer Diagnostic Procedure Market
20.1. Spain Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Gastric Cancer Diagnostic Procedure Market
21.1. Eastern Europe Gastric Cancer Diagnostic Procedure Market Overview
21.2. Eastern Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Gastric Cancer Diagnostic Procedure Market
22.1. Russia Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Gastric Cancer Diagnostic Procedure Market
23.1. North America Gastric Cancer Diagnostic Procedure Market Overview
23.2. North America Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Gastric Cancer Diagnostic Procedure Market
24.1. USA Gastric Cancer Diagnostic Procedure Market Overview
24.2. USA Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Gastric Cancer Diagnostic Procedure Market
25.1. Canada Gastric Cancer Diagnostic Procedure Market Overview
25.2. Canada Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Gastric Cancer Diagnostic Procedure Market
26.1. South America Gastric Cancer Diagnostic Procedure Market Overview
26.2. South America Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Gastric Cancer Diagnostic Procedure Market
27.1. Brazil Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Gastric Cancer Diagnostic Procedure Market
28.1. Middle East Gastric Cancer Diagnostic Procedure Market Overview
28.2. Middle East Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Gastric Cancer Diagnostic Procedure Market
29.1. Africa Gastric Cancer Diagnostic Procedure Market Overview
29.2. Africa Gastric Cancer Diagnostic Procedure Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Gastric Cancer Diagnostic Procedure Market, Segmentation By Offering Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Gastric Cancer Diagnostic Procedure Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Gastric Cancer Diagnostic Procedure Market Competitive Landscape And Company Profiles
30.1. Gastric Cancer Diagnostic Procedure Market Competitive Landscape
30.2. Gastric Cancer Diagnostic Procedure Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Johnson & Johnson Co
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. F. Hoffmann La Roche Ltd.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Merck & Co. Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Bayer AG
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Gastric Cancer Diagnostic Procedure Market Other Major And Innovative Companies
31.1. Novartis AG
31.2. Bristol-Myers Squibb Company
31.3. Thermo Fisher Scientific Inc.
31.4. AstraZeneca plc
31.5. Abbott Laboratories Inc.
31.6. Sanofi SA
31.7. Eli Lilly and Company
31.8. Otsuka Pharmaceutical Co Ltd.
31.9. AdventHealth
31.10. Atrium Health
31.11. Astellas Pharma Inc
31.12. Bausch Health Companies Inc.
31.13. Agilent Technologies Inc.
31.14. Ipsen Pharma
31.15. Hartford HealthCare
32. Global Gastric Cancer Diagnostic Procedure Market Competitive Benchmarking
33. Global Gastric Cancer Diagnostic Procedure Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Gastric Cancer Diagnostic Procedure Market
35. Gastric Cancer Diagnostic Procedure Market Future Outlook and Potential Analysis
35.1 Gastric Cancer Diagnostic Procedure Market In 2028 - Countries Offering Most New Opportunities
35.2 Gastric Cancer Diagnostic Procedure Market In 2028 - Segments Offering Most New Opportunities
35.3 Gastric Cancer Diagnostic Procedure Market In 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
